MERLIN INC (MRLN) Fundamental Analysis & Valuation

NASDAQ:MRLN • KYG1169T1040

Current stock price

6.3 USD
-0.62 (-8.96%)
At close:
6.9 USD
+0.6 (+9.52%)
Pre-Market:

This MRLN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MRLN Profitability Analysis

1.1 Basic Checks

  • MRLN had positive earnings in the past year.
  • MRLN had a negative operating cash flow in the past year.
MRLN Yearly Net Income VS EBIT VS OCF VS FCFMRLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2024 0 -200M -400M -600M

1.2 Ratios

Industry RankSector Rank
ROA 2.45%
ROE 2.57%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRLN Yearly ROA, ROE, ROICMRLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2024 0 5 10

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for MRLN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MRLN Yearly Profit, Operating, Gross MarginsMRLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MRLN Health Analysis

2.1 Basic Checks

  • MRLN has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for MRLN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MRLN Yearly Shares OutstandingMRLN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2024 10M 20M 30M
MRLN Yearly Total Debt VS Total AssetsMRLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • MRLN has an Altman-Z score of 10.64. This indicates that MRLN is financially healthy and has little risk of bankruptcy at the moment.
  • There is no outstanding debt for MRLN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.64
ROIC/WACCN/A
WACCN/A
MRLN Yearly LT Debt VS Equity VS FCFMRLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2024 0 200M -200M -400M -600M

2.3 Liquidity

  • MRLN has a Current Ratio of 0.43. This is a bad value and indicates that MRLN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MRLN has a Quick Ratio of 0.43. This is a bad value and indicates that MRLN is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.43
MRLN Yearly Current Assets VS Current LiabilitesMRLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2024 500K 1M 1.5M 2M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. MRLN Growth Analysis

3.1 Past

  • Measured over the past years, MRLN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -54.15% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5Y-54.15%
EPS Q2Q%278.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRLN Yearly Revenue VS EstimatesMRLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
MRLN Yearly EPS VS EstimatesMRLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

0

4. MRLN Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 33.16, MRLN can be considered very expensive at the moment.
  • When comparing the Price/Earnings ratio of MRLN to the average of the S&P500 Index (26.21), we can say MRLN is valued slightly more expensively.
Industry RankSector Rank
PE 33.16
Fwd PE N/A
MRLN Price Earnings VS Forward Price EarningsMRLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRLN Per share dataMRLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MRLN Dividend Analysis

5.1 Amount

  • MRLN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MRLN Fundamentals: All Metrics, Ratios and Statistics

MERLIN INC

NASDAQ:MRLN (4/7/2026, 8:53:31 PM)

Premarket: 6.9 +0.6 (+9.52%)

6.3

-0.62 (-8.96%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-12
Earnings (Next)N/A
Inst Owners88.38%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change92.43%
Market Cap212.69M
Revenue(TTM)N/A
Net Income(TTM)6.41M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 33.16
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.85
P/tB 0.85
EV/EBITDA N/A
EPS(TTM)0.19
EY3.02%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS7.38
TBVpS7.38
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.62
Profitability
Industry RankSector Rank
ROA 2.45%
ROE 2.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.43
Quick Ratio 0.43
Altman-Z 10.64
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5Y-54.15%
EPS Q2Q%278.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

MERLIN INC / MRLN Fundamental Analysis FAQ

What is the fundamental rating for MRLN stock?

ChartMill assigns a fundamental rating of 1 / 10 to MRLN.


What is the valuation status of MERLIN INC (MRLN) stock?

ChartMill assigns a valuation rating of 0 / 10 to MERLIN INC (MRLN). This can be considered as Overvalued.


What is the profitability of MRLN stock?

MERLIN INC (MRLN) has a profitability rating of 0 / 10.


Can you provide the PE and PB ratios for MRLN stock?

The Price/Earnings (PE) ratio for MERLIN INC (MRLN) is 33.16 and the Price/Book (PB) ratio is 0.85.